Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs

作者: L. Alvarez , G. Moreno , L. Moreno , L. Ceballos , L. Shaw

DOI: 10.1016/J.VETPAR.2009.05.014

关键词: OxfendazoleFlubendazoleHepaticaBiologyFasciola hepaticaMebendazoleAlbendazoleVeterinary medicineFenbendazoleTriclabendazole

摘要: The benzimidazole compounds albendazole (ABZ) and triclabendazole (TCBZ) are both effective against Fasciola hepatica, although ABZ is only adult flukes. Additionally, a broad-spectrum nematodicidal compound with well-known ovicidal activity. However, no data on the effect of TCBZ F. hepatica eggs available. work reported here evaluated comparative ABZ, their sulphoxide metabolites recovered from bile sheep artificially infected either TCBZ-susceptible (Cullompton) or TCBZ-resistant (Sligo) isolate hepatica. effects different non-flukicidal methylcarbamate hatching were evaluated. Eggs (500 eggs/mL, n=4) incubated for 12h TCBZ, (TCBZ.SO), (5, 10 20 nmol/mL) without drug (untreated control) (Experiment 1). TCBZ.SO (5 egg hatchability was examined after long (15 days) exposure 2). Furthermore, ABZ.SO at concentrations 1, 0.5, 0.1 0.05 3), fenbendazole (FBZ), oxfendazole (OFZ), mebendazole (MBZ), flubendazole (FLBZ) reduced-FLBZ (R-FLBZ) (2 microg/mL) fluke eggs, 12-h 4). Egg hatch assessed by direct microscopic observation incubation 25 degrees C 15 days. did not affect incubation. A similar result obtained much longer 1 significant (P<0.05) inhibition observed in ABZ- ABZ.SO-incubated (Experiments 3). 4) affected hatchability, particularly FLBZ R-FLBZ. In conclusion, had clear inhibitory development most extensively used flukicidal compound, its main metabolite, hatch, even

参考文章(41)
L. Alvarez, M. Mottier, S. Sánchez, C. Lanusse, Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica. Parasitology Research. ,vol. 87, pp. 929- 934 ,(2001) , 10.1007/S004360100471
L. C. Cork, Robert H. Schmidt, R. Johnson, S. Leary, W. Underwood, G. W. Thornton, B. McKiernan, E. Shull, P. Pascoe, F. Bain, R. Francis-Floyd, K. D. Amass, B. Kohn, B. T. Bennett, W. Reed, R. Schultz, B. V. Beaver, Report of the AVMA panel on euthanasia Javma-journal of The American Veterinary Medical Association. ,vol. 218, pp. 669- 696 ,(2001)
J A Bogan, S E Marriner, Pharmacokinetics of albendazole in sheep. American Journal of Veterinary Research. ,vol. 41, pp. 1126- 1129 ,(1980)
E. L. Roberson, N. H. Booth, L. E. McDonald, Anticestodal and antitrematodal drugs. Veterinary Pharmacology and Therapeutics.. pp. 928- 949 ,(1988)
W.C. Campbell, Benzimidazoles: Veterinary uses Parasitology Today. ,vol. 6, pp. 130- 133 ,(1990) , 10.1016/0169-4758(90)90231-R
Louise A. Ryan, Elizabeth Hoey, Alan Trudgett, Ian Fairweather, Marc Fuchs, Mark W. Robinson, Emma Chambers, David J. Timson, Eimear Ryan, Theresa Feltwell, Al Ivens, Geoffrey Bentley, David Johnston, Fasciola hepatica expresses multiple α- and β-tubulin isotypes Molecular and Biochemical Parasitology. ,vol. 159, pp. 73- 78 ,(2008) , 10.1016/J.MOLBIOPARA.2008.02.001
I. Fairweather, Triclabendazole progress report, 2005-2009: an advancement of learning? Journal of Helminthology. ,vol. 83, pp. 139- 150 ,(2009) , 10.1017/S0022149X09321173
D.W. Gottschall, V.J. Theodorides, R. Wang, The metabolism of benzimidazole anthelmintics Parasitology Today. ,vol. 6, pp. 115- 124 ,(1990) , 10.1016/0169-4758(90)90228-V